Sunday, December 20, 2009

Retinoblastoma protein (pRb) associated with better prognosis for TNBC

Triple negative breast cancer tumors that lack retinoblastoma protein (pRb) are much more likely to react positively to chemotherapy than TNBC tumors with pRb. Researchers studied 53 TNBC patients; at a follow-up of 105 months (8.75 years), all were disease-free after standard chemotherapy regimens. The research was published in the Annals of Oncology in June 2009 and was conducted in Bologna, Italy.

No comments: